Schedule 13G ownership disclosure

CRISPR Therapeutics AG

Security class unavailable · CUSIP: H17182108

Event date: 2021-08-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-114593
Form type
SC 13G/A
Filer
ARK Investment Management LLC
CIK
CIK 1697748
Filed
Sep 10, 2021
Reporting period
Aug 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub